FLGR 242 is a specialized synthetic derivative of the Follistatin-Related Gene (FLRG) sequence engineered for preclinical investigation of myostatin regulation and TGF-β superfamily receptor interaction. Supplied as a 30mg lyophilized research compound, this peptide provides laboratory investigators with a highly purified tool for analyzing skeletal muscle regulatory cascades in vitro.
FLGR 242 is a specialized synthetic derivative of the Follistatin-Related Gene (FLRG) sequence engineered for preclinical investigation of myostatin regulation and TGF-β superfamily receptor interaction. Supplied as a 30mg lyophilized research compound, this peptide provides laboratory investigators with a highly purified tool for analyzing skeletal muscle regulatory cascades in vitro.
FLGR 242 is a specialized research peptide derived from the Follistatin-Related Gene (FLRG) sequence, designed specifically for investigating TGF-β superfamily signaling and myostatin regulation in laboratory models. Supplied as a 30mg lyophilized solid, the flgr 242 peptide serves as a target ligand in in vitro receptor binding assays and preclinical tissue culture experiments examining muscle regulatory factor pathways.
In biochemical research, the flgr peptide structure is analyzed for its ability to bind neutralizing ligands within the myostatin (GDF-8) pathway without triggering classical Activin A cross-reactivity. Investigators utilize flgr 242 to map structural domains responsible for ligand sequestration, providing critical insight into gene transcription networks regulating satellite cell differentiation and hypertrophic muscle signaling.
The molecular architecture of the flgr-242 peptide centers on a conserved cysteine-rich domain structure derived from endogenous follistatin-like proteins. Endogenous follistatin and follistatin-related gene products function as natural antagonists to transforming growth factor-beta (TGF-β) family members, primarily myostatin and activins. The synthetic sequence designated as flgr 242 isolate key binding motifs designed to interact directly with the modern receptor-binding site of GDF-8.
Preclinical binding assays indicate that flgr-242 operates by forming high-affinity non-covalent complexes with circulating or localized myostatin molecules. By occupying the epitope required for Activin Receptor Type IIB (ActRIIB) engagement, the peptide prevents myostatin from initiating intracellular Smad2/3 phosphorylation pathways. In laboratory cell cultures, this blockade alters transcriptional regulation, downregulating muscle-degradation targets such as MuRF-1 and Atrogin-1 while permitting unabated Akt/mTOR signal transduction.
Research teams utilize the flgr 242 peptide across diverse experimental modalities focused on skeletal muscle biology, cellular differentiation, and tissue remodeling. In murine myoblast cell lines (such as C2C12), application of flgr-242 allows researchers to monitor changes in myotube diameter, fusion index, and nuclear positioning under conditions of controlled myostatin inhibition.
Beyond primary muscle cell assays, preclinical studies explore the compound's impact on fibrous tissue accumulation. Because myostatin promotes pro-fibrotic signaling in connective tissue matrices, incorporating an flgr peptide into cell culture assays enables precise measurement of collagen type I and type III expression via qPCR and Western blotting. Additional inquiries in our research library document how modulating TGF-β signaling cascades influences metabolic gene expression in adipocyte-myocyte co-culture models.
When designing protocols within the strength and myostatin-inhibition domain, researchers frequently evaluate FLGR 242 alongside related regulatory compounds. A critical distinction lies in peptide length, receptor specificity, and cross-reactivity profiles across the TGF-β superfamily.
Compared to native proteins like follistatin 315, which exhibits broad binding affinity for both Activin A and myostatin, flgr-242 features a truncated, domain-specific sequence designed to reduce non-target activin neutralization. Contrastingly, soluble receptor chimeras such as ace-031 function by mimicking the extracellular domain of ActRIIB, competing broadly for circulating ligands. Meanwhile, hypertrophic repair mechanisms can also be studied using splice-variant signaling peptides like peg-mgf, which stimulate muscle stem cell proliferation through distinct local IGF-1EB pathway activation rather than direct myostatin sequestration. Understanding these distinct target mechanisms allows laboratories to select the optimal peptide for specific cell-culture assay endpoints.
Preclinical quantitative assays demand high chemical purity and lot-to-lot consistency to prevent baseline data skewing. Contaminants, residual counter-ions, or bacterial endotoxins can induce non-specific inflammatory responses in cell cultures, invalidating transcriptional analyses. PX1 Research adheres to stringent analytical verification standards across our entire catalog of research peptides.
Every batch of FLGR 242 undergoes comprehensive quality control testing in an ISO 17025 accredited laboratory prior to release. Key verification metrics include:
• Purity Verification: Evaluated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) ensuring ≥98% purity profile. • Mass Verification: Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight and amino acid sequence identity. • Endotoxin Screening: Limulus Amebocyte Lysate (LAL) testing guarantees endotoxin levels below strictly enforced laboratory thresholds (<0.01 EU/mg). • Lyophilization Standards: Formulated in cGMP-compliant facilities with precise atmospheric control to prevent moisture absorption and peptide aggregation. • Chain of Custody: Each 30mg vial includes a dedicated lot number linked directly to its downloadable third-party Certificate of Analysis (COA).
All orders ship directly from domestic facilities in California and Arizona, with same-day fulfillment for orders placed Monday through Friday prior to cutoff times. Institutional research groups requiring bulk packaging can access specialized supply pipelines via our wholesale research portal.
Proper reconstitutive technique is vital to preserve the tertiary structural integrity of the flgr-242 peptide and prevent enzymatic or physical degradation. Upon receiving the 30mg lyophilized vial, store the container in a laboratory freezer at -20°C or -80°C prior to reconstitution.
For initial liquid preparation, introduce a sterile diluent such as Bacteriostatic Water or sterile 0.9% Sodium Chloride solution along the inner glass wall of the vial to minimize shear force. Gently swirl the vial until complete dissolution occurs; never vortex or vigorously shake peptide solutions. Reconstituted stock solutions should be aliquoted into single-use polypropylene micro-centrifuge tubes to prevent destructive freeze-thaw cycles and stored at -20°C. Working concentrations maintained at 4°C should be utilized within 7 to 14 days under sterile conditions.
Incorporating flgr 242 into in vitro experimental protocols requires careful optimization of molar concentration, incubation timing, and culture media composition. Investigators studying receptor binding kinetics typically establish gradient titrations ranging from 10 nM to 1 µM to map dosage-dependent suppression of ActRIIB activation.
Primary endpoints evaluated during flgr peptide experiments include Western blot quantification of phosphorylated Smad2 vs total Smad2, reporter gene assays utilizing CAGA-luciferase constructs, and immunofluorescence microscopy targeting myogenin and myosin heavy chain (MHC) expression. Researchers analyzing cell proliferation pathways may also cross-reference mechanisms investigated with cell-repair compounds such as bpc-157 or broader endocrine signaling regulators detailed in our guide on growth factor signaling cascades.
What is flgr 242?
FLGR 242 is a synthetic research peptide derived from the Follistatin-Related Gene (FLRG) sequence. It is designed for laboratory research investigating myostatin (GDF-8) inhibition, TGF-β superfamily signaling, and muscle cell regulatory mechanisms.
What is the primary mechanism of the flgr 242 peptide in research models?
The flgr 242 peptide functions as a myostatin antagonist by binding circulating or extracellular GDF-8, thereby preventing myostatin from binding to ActRIIB receptors and blocking downstream Smad2/3 signal transduction in cell culture models.
How should flgr-242 be stored upon receipt in the laboratory?
Lyophilized flgr-242 should be stored at -20°C or -80°C in a dry environment away from light. After reconstitution, aliquot the solution into single-use micro-centrifuge tubes and freeze at -20°C to avoid multiple freeze-thaw cycles.
What diluents are recommended for reconstituting an flgr peptide vial?
Laboratory standards recommend reconstituting the flgr peptide with sterile Bacteriostatic Water or sterile 0.9% Sodium Chloride injection solution under a laminar flow hood to maintain sterility.
Is flgr-242 peptide suitable for human administration or clinical use?
No. The flgr-242 peptide is strictly supplied as a research-grade chemical for in vitro, cell culture, and preclinical laboratory experimentation only. It is not approved for human or veterinary use.
How does FLGR 242 differ from native Follistatin-315?
While native Follistatin-315 binds broadly to both myostatin and Activin A, FLGR 242 is an engineered domain fragment optimized to selectively target myostatin with reduced activin neutralization.
How does PX1 Research verify the purity of FLGR 242 30mg?
PX1 Research verifies every lot of FLGR 242 using RP-HPLC for purity (≥98%) and ESI-MS for molecular mass verification. Every shipment includes access to a lot-specific Certificate of Analysis (COA) from an ISO 17025 accredited laboratory.
What are the endotoxin limits for PX1 Research flgr 242 vials?
All flgr 242 vials undergo Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin content remains strictly below 0.01 EU/mg, preventing non-specific cellular reactions during sensitive assays.
Can institutions purchase flgr 242 peptide in bulk quantities?
Yes, university departments, CROs, and institutional research labs can set up corporate research accounts and purchase bulk quantities via the PX1 Research wholesale portal.
What is the typical shipping timeline for flgr-242 orders?
Orders for flgr-242 placed Monday through Friday before our daily cutoff ship the same day from our CA or AZ fulfillment hubs via expedited courier service.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.